[ad_1]
Of the 300 million doses destined for the European Union, Italy would be entitled to 3.4 million doses of the anti-coronavirus vaccine produced by Pfizer and Biontech. Estimates are reported by Repubblica. The treatment was 90% effective in patients, according to the first results of the phase 3 study
Preliminary results from phase three trials of the coronavirus vaccine developed by Pfizer and Biontech have yielded positive results. The treatment was found to be 90% effective against Covid-19 infection and after the company’s announcement on Monday, November 9, the World Health Organization and global super experts like Anthony Fauci also spoke encouraging words. This is what we know so far about the distribution in Italy of the Pfizer vaccine, which from the second half of January could be available in our country for the vaccination of more than one and a half million people.
Pfizer’s Anti-Covid Vaccine in Italy
deepening
Covid, from Viagra to vaccines: the story of Pfizer and Biontech
The treatment is one of the most promising among those in development and again on Monday, November 9, European Commission President Ursula von der Leyen wrote in Twitter that the EU body will soon sign “a contract with Pfizer and Biontech to dispose of up to 300 million doses.” Specifically 200 million, with an option for another 100. Italy, of course, will be part of this pact. The commissioner also had contacts with other manufacturing companies and in June signed the first agreement with Astrazeneca. Italy had been one of the driving forces behind the firm along with France, Germany and the Netherlands. In that case, the number of doses disposed amounted to 400 million.
First details about the doses for our country
deepening
Coronavirus, where are the vaccines in the world
Repubblica, in an article published on Tuesday, November 10, reports that a “very confidential” meeting was held at the end of October between some representatives of Pfizer, a German company that produces drugs known as Xanax and Viagra. – prepare “vaccination against Covid for 1.7 million Italians as of the second half of January 2021.” Since the treatment requires two administrations, we are talking about 3.4 million doses destined for Italy. In terms of timing, Pfizer hopes to produce enough doses of its Covid-19 vaccine by the end of the year to immunize 15 to 20 million people. After having collected two months of data, necessary to guarantee security, therefore between November and December authorization from the EMA must arrive. Even if the last phase of the experimentation causes delays, for Repubblica January 20 (approximately) is a plausible date to start vaccination in Italy. Starting with the health workers and the weakest subjects, the guests of the RSA. The army will cooperate in transport and logistics.
[ad_2]
